Miller Anestesia

Basis of Therapeutics

. A continuación resulta prudente consultar

con dos expertos sobre el fármaco o la enfermedad y determinar

quién es el mejor capacitado para cuidar del paciente. El experto

mejor preparado debería ser observado mientras atiende al

paciente, no sólo preoperatoria e intraoperatoriamente, sino

también en el postoperatorio. Es importante recordar que pocos

ensayos controlados prospectivos han demostrado que ninguna

técnica, tratamiento o manejo preoperatorio reduzca el riesgo

perioperatorio. Sin embargo, el sentido común y el conocimiento

a priori de los posibles errores, además de la diligencia en evi

tarlos, deberían reducir las complicaciones perioperatorias

evitables.

Bibliografía

1. Thorpe KE, Howard DH, Galactionova K: Differen-

ces in disease prevalence as a source of the U.S.

-European health care spending gap. Health Affairs

26:w678–w686, 2007.

2. Wei JY: Age and the cardiovascular system. N Engl

J Med 327:1735, 1992.

3. Perioperative medicine.

Medical Knowledge Self-

Assessment Program 14,General Internal Medicine.

Philadelphia,American College of Physicians, 2006,

p 128.

4. Roizen M: The preoperative cardiology consult:

What the cardiologist should know about anesthe-

sia. In Parmley W, Chatterjee K (eds): Cardiology.

Philadelphia, JB Lippincott, 1993, p 1.

5. Wilson SH, Fasseas P, Orford JL, et al: Clinical

outcome of patients undergoing non-cardiac

surgery in the two months following coronary

stenting. J Am Coll Cardiol 42:234–240, 2003.

6. Fleisher LA, Eagle KA: Clinical practice. Lowering

cardiac risk in noncardiac surgery. N Engl J Med

345:1677, 2001.

7. Goldman L, Caldera DL, Nussbaum SR, et al: Mul-

tifactorial index of cardiac risk in noncardiac sur-

gical procedures. N Engl J Med 297:845, 1977.

8. Fleisher LA, Beckman JA, Brown KA, et al: ACC/

AHA 2007 guidelines on perioperative cardiovascular

evaluation and care for noncardiac surgery—a report

of the American College of Cardiology/American

Heart Association Task Force on Practice Guidelines

(Writing Committee to Revise the 2002 Guidelines on

Perioperative Cardiovascular Evaluation for Noncar-

diac Surgery). J Am Coll Cardiol 50:159–211, 2007.

9. Krinsley JS: Effect of an intensive glucose manage-

ment protocol on the mortality of critically ill adult

patients. Mayo Clin Proc 79:992–1000, 2004.

10. AdvanceCollabor

ativeGroup:Intensivebroadglucose

control and vascular outcomes in patients with type

2 diabetes. N Engl J Med 358:2560–2572, 2008.

11. Van den Berghe G, Wouters P, Weekers F, et al:

Intensive insulin therapy in critically ill patients. N

Engl J Med 345:1359–1367, 2001.

12. Ingels C, Debaveye Y, Milants I, et al: Strict blood

glucose control with insulin after cardiac surgery:

Impact on 4-year survival, depending on medical

care, and quality of life. Eur Heart J 27:2716–2724,

2006.

13. Finney SJ, Zekveld C, Elia A, Evans TW: Glucose

control and mortality in critically ill patients. JAMA

290:2041–2047, 2003.

14. Krinsley JS: Association between hyperglycemia

and increased hospital mortality in a heterogeneous

population of critically ill patients. Mayo Clin Proc

78:1471–1478, 2003.

15. The Diabetes Control and Complications Trial

(DCCT)/Epidemiology of Diabetes Interventions

and Complications Research Group: Retinopathy

and nephropathy in patients with type I diabetes

four years after a trial of intensive therapy. N Engl

J Med 342:381–389, 2000.

16. UK Prospective Diabetes Study Group: Tight blood

pressure control and risk of macrovascular and

microvascular complications in type II diabetes.

BMJ 317:703–713, 1998.

17. Albacker T, Carvalho G, Schricker T, et al: High-

dose insulin therapy attenuates systemic inflamma-

tion response in coronary artery bypass grafting

patients. Ann Thorac Surg 86:20–27, 2008.

18. Freeman R: Autonomic peripheral neuropathy.

Lancet 365:1259–1270, 2005.

19. Charlson ME, MacKenzie CR, Gold JP: Preopera-

tive autonomic function abnormalities in patients

with diabetes mellitus and patients with hyperten-

sion. J Am Coll Surg 179:1, 1994.

20. Kalichman MW, Calcutt NA: Local anesthetic–

induced conduction block and nerve fiber injury in

streptozotocin-diabetic rats.Anesthesiology 77:941,

1992.

21. Roizen MF: RealAge: Are You As Young As You Can

Be? New York, HarperCollins, 1999.

22. Roizen MF: The RealAge Makeover: Take Years Off

Your Looks and Add Them to Your Life! New York,

HarperCollins, 2004.

23. Roizen MF, Oz MC: YOU: The Owner’s Manual.

New York, HarperCollins, 2005.

24. Dormandy JA, Charbonnel B, Ecklund DJ, et al:

Secondary prevention of mascrovascular events in

patients with type 2 diabetes in the PROactive Study

(PROspective pioglitAzone Clinical Trial In macro

Vascular Events): A randomized controlled trial.

Lancet 366:1279–1289, 2005.

25. Nolan CM, Beaty HN, Bagdade JD: Further charac-

terization of the impaired bactericidal function of

granulocytes in patients with poorly controlled

diabetes. Diabetes 27:889, 1978.

26. Cruse PJ, Foord R: A 5-year prospective study of

23,649 surgical wounds. Arch Surg 107:206, 1973.

27. Longstreth WT, Inui TS: High blood glucose level

on hospital admission and poor neurological

recovery after cardiac arrest. Ann Neurol 15:59,

1984.

28. Johnson WD, Pedraza PM, Kayser KL: Coronary

artery surgery in diabetics: 261 consecutive patients

followed four to seven years. Am Heart J 104:823–

827, 1982.

29. Borow KM, Jaspan JB, Williams KA, et al: Myocar-

dial mechanics in young adult patients with diabetes

mellitus: Effects of altered load, inotropic state and

dynamic exercise. J Am Coll Cardiol 15:1508, 1990.

30. Chiasson JL, Aris-Jilwan N, Belanger R, et al: Diag-

nosis and treatment of diabetic ketoacidosis and the

hyperglycemic hyperosmolar state. CMAJ 168:859–

866, 2003.

31. The Diabetes Control and Complications Trial

Research Group: Effect of intensive therapy on

residual

-cell function in patients with type 1

diabetes in the Diabetes Control and Complications

Trial. A randomized, controlled trial. Ann Intern

Med 128:517, 1998.

32. Ramanathan S, Khoo P, Arismendy J: Perioperative

maternal and neonatal acid-base status and glucose

metabolism in patients with insulin-dependent

diabetes mellitus. Anesth Analg 73:105, 1991.

33. Khuri SF, Daley J, Henderson W, et al: Risk adjus-

tment of the postoperative mortality rate for the

comparative assessment of the quality of surgical

care: Results of the National Veterans Affairs Surgi-

cal Risk Study. J Am Coll Surg 185:315, 1997.

34. Tuomilehto J, Lindstrom J, Eriksson JG, et al:

Finnish Diabetes Prevention Study Group. Preven-

tion of type 2 diabetes mellitus by changes in lifes-

tyle among subjects with impaired glucose tolerance.

N Engl J Med 344:1343–1350, 2001.

35. Ravid M, Brosh D, Levi Z, et al: Use of enalapril to

attenuate decline in renal function in normotensive,

normoalbuminuric patients with type 2 diabetes

mellitus.A randomized, controlled trial.Ann Intern

Med 128:982, 1998.

36. Page MM, Watkins PJ: Cardiorespiratory arrest

and diabetic autonomic neuropathy. Lancet 1:14,

1978.

37. Pasternak JJ, McGregor DG, Schroeder DR, et al:

Hypoglycemia in patients undergoing cerebral

aneurysm surgery: Its association with long-term

gross neurologic and neuropsychological function.

Mayo Clin Proc 83:406–417, 2008.

38. Larsen ML, Illingworth DR: Drug treatment of

dyslipoproteinemia. Med Clin North Am 78:225,

1994.

39. Downs JR, Clearfield M, Weis S, et al: Primary

prevention of acute coronary events with lovastatin

in men and women with average cholesterol levels.

Results of AFCAPS/TexCAPS. JAMA 279:1615,

1998.

40. Fowkes FGR, Price JF, Leng GC: Targeting subclini-

cal atherosclerosis. BMJ 316:1764, 1998.

41. Nissen SE, Tazcu EM, Schoenhagen P, et al: Effect of

intensive compared with moderate lipid-lowering

therapy on progression of coronary atherosclerosis.

A randomized clinical trial. JAMA 291:1071–1080,

2004.

42. Pelosi P, Croci M, Ravagnan I, et al: Respiratory

system mechanics in sedated, paralyzed, morbidly

obese patients. J Appl Physiol 82:811–818, 1997.

43. Daniels L: Good nutrition for good surgery: Clini-

cal and quality of life outcomes. Australian Pres-

criber 26:136–140, 2003.

44. Donini LM, Savina C, Cannella C: Eating habits and

appetite control in the elderly: The anorexia of

aging. Int Psychogeriatr 15:73–87, 2003.

45. Veterans Administration Total Parenteral Nutrition

Cooperative Study Group: Perioperative total

parenteral nutrition in surgical patients. N Engl J

Med 325:525, 1991.

46. Nicholas JM, Cornelius MW, Tchorz KM, et al: A

two institution experience with 226 endoscopically

placed jejunal feeding tubes in critically ill surgical

patients. Am J Surg 186:583–590, 2003.

47. Starker PM, La Sala PA, Askanazi J, et al: The res-

ponses to TPN, a form of nutritional assessment.

Ann Surg 198:720, 1983.

48. Udelsman R, Ramp J, Gallucci WT, et al: Adaptation

during surgical stress: A reevaluation of the role of

glucocorticoids. J Clin Invest 77:1377, 1986.

49. Lampe GH, Roizen MF: Anesthesia for patients

with abnormal function of the adrenal cortex.Anes-

thesiol Clin North Am 5:245, 1987.

50. Ezzat S,Asa SL, Couldwell WT, et al: The prevalence

of pituitary adenomas: A systematic review. Cancer

101:613–619, 2004.

51. Symreng T, Karlberg BE, Kågedal B, et al: Physiolo-

gical cortisol substitution of long-term steroid-

treated patients undergoing major surgery. Br J

Anaesth 53:949, 1981.

52. Nieman LK, Oldfield EH, Wesley R, et al: A sim-

plifiedmorning corticotrophin-releasing hormone

stimulation test for the differential diagnosis of

adrenocorticotrophin-dependent

Cushing’s

syndrome. J Clin Endocrinol Metab 77:1308, 1993.

53. Dorin RI, Qualls CR, Crapo LM: Diagnosis of

adrenal insufficiency.Ann Intern Med 139:194–204,

2003.

Implicaciones anestésicas de las enfermedades concurrentes

907

Sección III

Control de la anestesia